使用强化学习进行个性化血液动力学管理,以预防心脏手术后持续的急性损伤
medRxiv : the preprint server for health sciences
|November 24, 2025
概括
这项研究开发了一种强化学习 (RL) 模型,以个性化心脏手术后的血液动力学管理,降低持续急性损伤 (pAKI) 的风险. 由人工智能指导的策略显示出改善患者治疗结果的前景.
科学领域:
- 关键护理医学 关键护理医学
- 医疗保健中的人工智能
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 急性损伤 (AKI) 是心脏手术后的一种严重并发症,持续的AKI (pAKI) 会导致更糟糕的结果.
- 目前的血液动力学管理依赖于实施不一致的捆绑干预措施,强调需要个性化方法.
研究的目的:
- 开发和验证一种强化学习 (RL) 模型,用于对静脉注射液体,血管压缩剂和异型药物的个性化剂量.
- 其目标是预防心脏手术患者的持续性AKI (pAKI).
主要方法:
- 追溯队列研究,涉及模型开发和验证在MIMIC-IV,SICdb和西奈山卫生系统数据库.
- 利用RL优化基于奖励式学习的治疗政策.
- 使用Fitted Q评估和后勤回归对临床医生管理进行评估模型性能.
主要成果:
- 在所有队列中,RL模型实现了比临床医生政策更高的累积奖励.
- 临床医生的行动与RL建议之间的协调与减少pAKI的几率有关.
- 与标准护理相比,RL模型建议更小的静脉液体体积和调整的血管压缩剂/诺托罗普剂量.
结论:
- 使用RL模型进行个性化血液动力学管理,表明心脏手术后pAKI风险降低.
- 人工智能引导的血液动力学策略有可能提高术后护理.
- 在随机临床试验中进行进一步的测试是有必要的,以证实这些发现.
相关概念视频
01:22Acute Kidney Injury VI: Nursing Management
371
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
371
01:30Continuous Renal Replacement Therapy
768
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
768
01:20Acute Kidney Injury V: Interprofessional Care
284
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
284
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
249
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
249
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
895
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
895
01:22Acute Kidney Injury I: Introduction
536
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
536